Related Experiment Video
Updated: Nov 20, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Cytomegalovirus-Associated Venous and Arterial Thrombotic Disease
Amar H Kelkar1, Brian L Loc2, Michael D Tarantino3
1Division of Hematology & Oncology, University of Florida College of Medicine, Gainesville, USA.
Insights
Cytomegalovirus (CMV) infection significantly increases the risk of venous thromboembolism (VTE) and acute coronary syndromes (ACS). This study found higher incidences of VTE and ACS in patients with active CMV infection compared to controls.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Thrombosis and Hemostasis
Background:
- Cytomegalovirus (CMV) infection is a known factor linked to cardiovascular events.
- Previous associations between CMV and venous thromboembolism (VTE) and acute coronary syndromes (ACS) warrant further investigation.
Purpose of the Study:
- To determine the incidence of acute VTE and ACS within one year following CMV testing.
- To evaluate CMV infection as a potential risk factor for VTE and ACS.
Main Methods:
- A retrospective study analyzed patient data from the OSF HealthCare System.
- Patients were categorized into three groups: CMV infection (positive IgM or PCR), seropositive control (positive IgG, negative IgM), and seronegative control (negative IgG and IgM, or negative PCR).
- Incidence of VTE and ACS within one year of CMV testing was compared across groups, with adjustments for age and gender.
Main Results:
- Patients with CMV infection showed a significantly higher incidence of VTE (10.0%) compared to seropositive (3.1%) and seronegative (3.0%) controls.
- The incidence of ACS was also higher in the CMV infection group (7.7%) versus seropositive (4.7%) and seronegative (1.9%) controls.
- Adjusted analyses confirmed that CMV infection was associated with increased odds of VTE and ACS.
Conclusions:
- CMV infection is a significant risk factor for developing VTE.
- CMV infection may also contribute to the occurrence of ACS.
- Further research is recommended to elucidate the mechanisms linking CMV infection to thrombotic and cardiovascular events.
Background:
Cytomegalovirus (CMV) infection has been associated with venous thromboembolism (VTE) and acute coronary syndromes (ACS).
Methods:
A retrospective study was conducted within the OSF HealthCare System in Peoria, IL. The objectives were to determine the incidence of acute VTE and ACS within one year of CMV testing. The "study group" included patients with positive CMV immunoglobulin M (IgM) or positive CMV polymerase chain reaction (PCR). The "seropositive control" group included patients with positive CMV immunoglobulin G (IgG) and negative IgM. The "seronegative control" group included patients with negative CMV IgG and IgM, or negative PCR.
Results:
Within one year of CMV infection, 38 of 379 patients (10.0%) developed VTE in the study group compared to 41 of 1334 patients (3.1%) in the seropositive control and 37 of 1249 (3.0%) in the seronegative control. Adjusting for age and gender, both control groups were less likely to have VTE than the study group within one year (seropositive control: odds ratio (OR) = 0.3, 95% confidence interval (CI) 0.2-0.5, p < 0.0001; seronegative control: OR = 0.4, 95% CI 0.2-0.6, p < 0.0001). ACS was more likely to occur in the study group, with the incidence of 7.7% compared to 4.7% (p < 0.0001) in the seropositive control and 1.9% (p <0.0001) in the seronegative control. Adjusting for age and gender, the seronegative control was less likely to develop ACS than the study group within one year (OR = 0.4, 95% CI 0.2-0.7, p = 0.003).
Conclusions:
This retrospective study demonstrates that CMV infection may be a significant risk factor for VTE and ACS.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

